Latest News about JNJ
Recent news which mentions JNJ
The 7 Most Undervalued Dividend Stocks to Buy in December
December 15, 2023
From InvestorPlace
AC Immune Raises $50M, Its Alzheimer's Targeting Immunotherapy Advances Into Phase 2b Trial
December 15, 2023
From Benzinga
3 Dow Stocks I Wouldn’t Touch With a 10-Foot Pole
December 14, 2023
From InvestorPlace
Ryan Cohen Plans to Save GameStop By Becoming Warren Buffett
December 14, 2023
From InvestorPlace
Rain Oncology Goes Private Just Two Years After $120M NASDAQ Debut
December 14, 2023
From Benzinga
Neurosurgery Focused Integra LifeSciences Bolsters Its ENT Portfolio With $275M Acquisition Deal
December 13, 2023
From Benzinga
Economic Safety Nets: 7 Defensive Stocks Providing Portfolio Stability
December 13, 2023
From InvestorPlace
From Benzinga
Seeking Passive Income? 7 Dividend Stocks You Don’t Want to Miss.
December 13, 2023
From InvestorPlace
From InvestorPlace
From Benzinga
Gilead Sciences Battles Rising Threat of Drug Counterfeiting, Initiates Legal Actions
December 11, 2023
From Benzinga
2 Top Dividend Stocks to Buy Now
December 11, 2023
From Motley Fool
5 Phenomenal Stocks in Warren Buffett's "Secret" Portfolio That Are Screaming Buys in 2024
December 11, 2023
From Motley Fool
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
December 08, 2023
From Benzinga
7 Tech Stocks to Light Up Your Portfolio This Holiday Season
December 08, 2023
From InvestorPlace
Walgreens’ stock soars 8% to lead Dow gainers but is still on track for worst year since 1972
December 07, 2023
From MarketWatch
Investing in the Aging Population: 3 Healthcare Stocks to Watch
December 07, 2023
From InvestorPlace
Vanda Pharmaceuticals Acquires Rights To Multiple Sclerosis Drug From Johnson & Johnson's Company
December 07, 2023
From Benzinga
JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different Priorities
December 06, 2023
From Benzinga
Bargain Buys: 7 Stocks Lagging the S&P 500 With Big Potential
December 06, 2023
From InvestorPlace
Johnson & Johnson Settles Multiple Lawsuits Over Talc Cancer Claims, Eyes Prepackaged Bankruptcy
December 06, 2023
Tickers
JNJ
From Benzinga
Is Buffett Turning Bearish? 7 Stocks Warren Completely Dumped in Q3
December 05, 2023
From InvestorPlace
Johnson & Johnson's Strategic Forecast: Targets 5%-6% Operational Sales Growth For FY24
December 05, 2023
Tickers
JNJ
From Benzinga
Unleashing Growth Potential: Johnson & Johnson Surpasses Expectations with Strong Performance and Increasing Profits
December 05, 2023
From Benzinga
The 7 Best Ways to Invest $1,000 in the Stock Market Now
December 04, 2023
Tags
NVDA
NYSE:JNJ,NASDAQ:PEP,NASDAQ:SOFI,NASDAQ:TSLA,NASDAQ:AMZN,NASDAQ:NVDA,NYSE:PLTR,NYSE:TSM,NASDAQ:AAPL
Market News
From InvestorPlace
Top Contenders Emerge in Johnson & Johnson's Race for New CEO, Plans Under Spotlight After Unexpected Departure
December 04, 2023
Tickers
JNJ
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.